R. Connolly, Fengmin Zhao, K. Miller, Min-Jung Lee, R. Piekarz, K. Smith, U. Brown-Glaberman, J. Winn, B. Faller, A. Onitilo, M. Burkard, G. Budd, E. Levine, M. Royce, P. Kaufman, Alexandra Thomas, J. Trepel, A. Wolff, J. Sparano
{"title":"GS4-02: E2112:内分泌治疗联合恩替诺他/安慰剂治疗激素受体阳性晚期乳腺癌的随机3期临床试验。ECOG-ACRIN癌症研究小组的一项试验","authors":"R. Connolly, Fengmin Zhao, K. Miller, Min-Jung Lee, R. Piekarz, K. Smith, U. Brown-Glaberman, J. Winn, B. Faller, A. Onitilo, M. Burkard, G. Budd, E. Levine, M. Royce, P. Kaufman, Alexandra Thomas, J. Trepel, A. Wolff, J. Sparano","doi":"10.1158/1538-7445.sabcs20-gs4-02","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12697,"journal":{"name":"General Session Abstracts","volume":"67 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Abstract GS4-02: E2112: Randomized phase 3 trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN cancer research group\",\"authors\":\"R. Connolly, Fengmin Zhao, K. Miller, Min-Jung Lee, R. Piekarz, K. Smith, U. Brown-Glaberman, J. Winn, B. Faller, A. Onitilo, M. Burkard, G. Budd, E. Levine, M. Royce, P. Kaufman, Alexandra Thomas, J. Trepel, A. Wolff, J. Sparano\",\"doi\":\"10.1158/1538-7445.sabcs20-gs4-02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12697,\"journal\":{\"name\":\"General Session Abstracts\",\"volume\":\"67 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"General Session Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.sabcs20-gs4-02\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"General Session Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.sabcs20-gs4-02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Abstract GS4-02: E2112: Randomized phase 3 trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer. A trial of the ECOG-ACRIN cancer research group